US2561352038
US2561352038
Dr. Reddy's Laboratories Ltd
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 335.933.000.000 | 325.535.000.000 | 3.2% |
| Cost of Revenue | 158.669.000.000 | 135.107.000.000 | 17.4% |
| Gross Profit | 177.264.000.000 | 190.428.000.000 | 6.9% |
| 127.141.000.000 | 118.414.000.000 | 7.4% | |
| Operating Income | 50.123.000.000 | 72.014.000.000 | 30.4% |
| Pretax Income | 54.817.000.000 | 76.784.000.000 | 28.6% |
| Net Income Common Stockholders | 42.850.000.000 | 56.544.000.000 | 24.2% |
| -- | -- | -- | |
| -- | -- | -- |